(Q35397342)

8 August 2017

1 reference

title

ACE inhibitors in renal disease. (English)

1 reference

8 August 2017

Brunner HR

1

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 August 1992

1 reference

8 August 2017

1 reference

8 August 2017

volume

42

1 reference

8 August 2017

issue

2

1 reference

8 August 2017

page(s)

463-479

1 reference

Vascular renin-angiotensin system: the unanswered questions

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Renin substrate in rat mesenteric artery

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Renin synthesis by canine aortic smooth muscle cells in culture

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Tissue and gene specificity of mouse renin expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Arterial wall uptake of renal renin and blood pressure control

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Inhibition of renin secretion by angiotensin. II.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

The pathogenic role of the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Intrarenal role of angiotensin II. Homeostatic regulation of renal blood flow in the dog.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Renal adaptation to sodium deprivation. Effect of captopril in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Sodium intake and renal responses to captopril in normal man and in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Renin- and non-renin–mediated antihypertensive actions of converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Effect of Captopril on Renal Vascular Tone in Patients with Essential Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Prolonged converting enzyme inhibition in non-modulating hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1992.311

1 reference

7 January 2021

Effect of angiotensin II antagonist infusion on autoregulation of renal blood flow

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Effects of converting-enzyme inhibition on cardiorenal hemodynamics in patients with chronic congestive heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Hemodynamic and renal function in essential hypertension during treatment with enalapril

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Renal prostaglandins: possible regulators of the renal actions of pressor hormones.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Clinical effects of prostaglandins in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Nonsteroidal antiinflammatory drugs and renal function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Evidence for renal glomerular receptors for angiotensin II

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Evidence for mesangial glomerular receptors for angiotensin II linked to mesangial cell contractility

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Contraction of Cultured Rat Glomerular Cells of Apparent Mesangial Origin after Stimulation with Angiotensin II and Arginine Vasopressin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Relative contribution of vasopressin and angiotensin II to the altered renal microcirculatory dynamics in two-kidney Goldblatt hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Effect of intrarenal angiotensin II blockade on renal function in conscious dogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Inactive renin: an attempt at a perspective

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Effect of Captopril and Aprotinin on Inactive Renin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Reciprocal Changes in Active and Inactive Renin after Converting Enzyme Inhibition in Normal Man*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Lack of angiotensin I accumulation after converting enzyme blockade by enalapril or lisinopril in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

The hypotensive effect of propranolol in captopril-treated patients does not involve the plasma renin--angiotensin--aldosterone system

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

The antihypertensive effect of captopril in essential hypertension: relationship to prostaglandins and the kallikrein-kinin system

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Escape from Mineralocorticoid Excess: The Role of Angiotensin II

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Antihypertensive Therapy with MK 4211

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

In vitro renin inhibition to prevent generation of angiotensins during determination of angiotensin I and II

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Determinants of angiotensin II generation during converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Reactive Hyperreninemia Is a Major Determinant of Plasma Angiotensin II During ACE Inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

THE EFFECTS OF INTRAVENOUS INFUSIONS OF VALINE-5 ANGIOTENSIN II AND OTHER PRESSOR AGENTS ON URINARY ELECTROLYTES AND CORTICOSTEROIDS, INCLUDING ALDOSTERONE.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Inhibition of distal tubular sodium reabsorption by angiotensin. II

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Tubuloglomerular Feedback and Single Nephron Function after Converting Enzyme Inhibition in the Rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Angiotensin II binding sites on isolated rat renal brush border membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Angiotensin II-Binding Sites in Rat and Primate Isolated Renal Tubular Basolateral Membranes*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Proximal nephron and renal effects of DuP 753, a nonpeptide angiotensin II receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Abnormal relation between exchangeable sodium and the renin-angiotensin system in malignant hypertension and in hypertension with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Innappropriate renin secretion unmasked by captopril (SQ 14 225) in hypertension of chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Renal effects of angiotensin converting enzyme inhibitors in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Effect of Saralasin in Hypertensive Patients on Chronic Hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Hemodialysis-Resistant Hypertension: Control with an Orally Active Inhibitor of Angiotensin-Converting Enzyme*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Suppression of plasma renin activity by cyclosporine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

The long-term course of cyclosporine-associated chronic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Effect of cyclosporine administration on renal hemodynamics in conscious rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Cyclosporine A enhances renin secretion and production in isolated juxtaglomerular cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Antihypertensive Effect of Prolonged Blockade of Angiotensin Formation in Benign and Malignant, one- and two-Kidney Goldblatt Hypertensive Rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Long-term efficacy of captopril in renovascular and essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Enalapril in the treatment of hypertension with renal artery stenosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Renovascular hypertension: treatment with the oral angiotensin-converting enzyme inhibitor enalapril

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Ramipril for hypertension secondary to renal artery stenosis. Changes in blood pressure, the renin-angiotensin system and total and divided renal function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Enhancement by Diuretics of the Antihypertensive Action of Long-Term Angiotensin Converting Enzyme Blockade

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Hypertensive crisis treated with orally administered captopril

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Pharmacokinetics of repeated single oral doses of enalapril maleate (mk-421) in normal volunteers

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Preferential biliary elimination of FPL 63547, a novel inhibitor of angiotensin-converting enzyme, in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Comparison of the Steady-State Pharmacokinetics of Fosinopril, Lisinopril and Enalapril in Patients with Chronic Renal Insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Chronic effects of dietary protein in the rat with intact and reduced renal mass

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Dietary protein restriction in established renal injury in the rat. Selective role of glomerular capillary pressure in progressive glomerular dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Renal vascular effects of antihypertensive therapy in uninephrectomized SHR.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

A simple method of estimating progression of chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Progression of renal insufficiency: role of blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

The effect of treatment on the vascular deterioration associated with hypertension, with particular emphasis on renal function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Reduction of proteinuria by angiotensin converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Short-term effect of captopril on renal haemodynamics in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Renal effects of enalapril in hypertensive patients with glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function. A retrospective study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Comparison of the effects of calcium antagonists and converting enzyme inhibitors on renal function under normal and hypertensive conditions.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Effects of calcium channel blockade on renal vascular resistance responses to changes in perfusion pressure and angiotensin-converting enzyme inhibition in dogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Effect of the calcium channel blocker nisoldipine on the progression of chronic renal failure in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Effect of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Long-term improvement in renal function after short-term strict blood pressure control in hypertensive nephrosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Pathogenesis of diabetic microangiopathy. The hemodynamic view

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Short and long term effects of antihypertensive therapy in the diabetic rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Effect of captopril on heavy proteinuria in azotemic diabetics

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Immune-complex glomerulopathy in patients treated with captopril

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Captopril-Induced Functional Renal Insufficiency in Patients with Bilateral Renal-Artery Stenoses or Renal-Artery Stenosis in a Solitary Kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Angiotensin converting enzyme inhibition in renovascular hypertension: frequency of reversible renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Reversible renal failure during treatment with captopril

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Reactive Hyperreninemia in Renovascular Hypertension After Angiotensin Blockade with Saralasin or Converting Enzyme Inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.311

7 January 2021

Identifiers

DOI

10.1038/KI.1992.311

1 reference

Dimensions Publication ID

8 August 2017

1001736234

0 references

1 reference